首页|期刊导航|世界中医药|十味咳喘方改善慢性阻塞性肺疾病气道黏液高分泌的作用机制

十味咳喘方改善慢性阻塞性肺疾病气道黏液高分泌的作用机制OACHSSCD

Mechanisms of Shiwei Kechuan Formula in Improving Airway Mucus Hypersecretion of Chronic Obstructive Pulmonary Disease

中文摘要英文摘要

目的:评价十味咳喘方祛痰、止咳、抗炎药效,并探索其改善慢性阻塞性肺疾病(COPD)气道黏液高分泌的作用机制.方法:采用8.5、17、34 g/kg生药剂量对小鼠进行十味咳喘方灌胃,通过酚红气道排泌试验、浓氨水诱导咳嗽试验、二甲苯所致耳肿胀试验,分别评价其祛痰、止咳、抗炎效果.利用香烟烟雾联合脂多糖(LPS)气道滴注构建COPD模型,采用酶联免疫吸附试验(ELISA)法测定肺泡灌洗液(BALF)中黏蛋白(MUC)5AC和MUC5B含量,运用定量逆转录聚合酶链反应法(RT-qPCR)测定肺组织MUC5AC和MUC5B mRNA表达水平,通过蛋白质印迹法(WB)分析肺组织κB抑制因子激酶β(IKKβ)、核因子κB(NF-κB)p65、磷酸化的κB抑制因子α(p-IKBα)和κB抑制因子α(IκBα)表达水平,并采用苏木精-伊红(HE)染色法观察肺组织病理变化.结果:十味咳喘方可显著提升酚红气道排出量,延长浓氨水诱导的咳嗽潜伏期、减少咳嗽次数,降低二甲苯所致耳肿胀程度(P<0.05).该方可显著改善COPD模型小鼠肺组织病理变化,降低模型小鼠BALF中MUC5AC和MUC5B含量,下调肺组织MUC5AC和MUC5B mRNA表达,抑制IKKβ表达,减少NF-κB p65表达,降低IκBα磷酸化水平并抑制其降解(P<0.05).结论:十味咳喘方具有显著的祛痰、止咳、抗炎作用,并能改善COPD小鼠模型气道黏液高分泌,这一作用机制可能与抑制NF-κB信号通路激活有关.

Objective:To evaluate the expectorant,antitussive,and anti-inflammatory effects of Shiwei Kechuan Formula and ex-plore its mechanisms of action in improving airway mucus hypersecretion in chronic obstructive pulmonary disease(COPD).Meth-ods:Mice were administered Shiwei Kechuan Formula by gavage at crude drug doses of 8.5,17,and 34 g/kg.The expectorant,anti-tussive,and anti-inflammatory effects were evaluated using the phenol red airway excretion test,concentrated ammonium hydroxide-induced cough test,and xylene-induced ear swelling test,respectively.A COPD model was established by cigarette smoke exposure combined with airway instillation of lipopolysaccharide(LPS).The levels of mucins(MUC)5AC and MUC5B in bronchoalveolar lavage fluid(BALF)were measured by enzyme-linked immunosorbent assay(ELISA).The mRNA expression levels of MUC5AC and MUC5B in lung tissue were determined by quantitative reverse transcription polymerase chain reaction(RT-qPCR).The ex-pression levels of inhibitor of κB kinase β(IKKβ),nuclear factor-KB(NF-κB)p65,phosphorylated inhibitor of κBα(p-IκBα),and inhibitor of κBα(IκBα)in lung tissue were analyzed by Western blot(WB).Pathological changes in lung tissue were observed by hematoxylin-eosin(HE)staining.Results:Shiwei Kechuan Formula significantly increased phenol red airway excretion,prolonged the latency period of concentrated ammonium hydroxide-induced cough,reduced the number of coughs,and decreased the degree of xylene-induced ear swelling(P<0.05).The formula significantly improved pathological changes in the lung tissue of COPD model mice,reduced MUC5AC and MUC5B levels in BALF,downregulated MUC5AC and MUC5B mRNA expression in lung tissue,inhib-ited IKKβ expression,reduced NF-κB p65 expression,decreased the phosphorylation level of Iκ Bα,anid inhibited its degradation(P<0.05).Conclusion:Shiwei Kechuan Formula has significant expectorant,antitussive,and anti-inflammatory effects and can improve airway mucus hypersecretion in COPD model mice.This mechanism may be associated with inhibition of NF-κB signaling pathway activation.

余梦瑶;刘若阳;许晓燕;王腾飞;李芳;余德海;罗霞

四川省中医药科学院,成都,610041||中药新药创制川渝共建重点实验室,成都,610041||中药品质及新药创制四川省重点实验室,成都,610041四川省中医药科学院中医研究所(四川省第二中医医院),成都,610031四川省中医药科学院,成都,610041||中药新药创制川渝共建重点实验室,成都,610041||中药品质及新药创制四川省重点实验室,成都,610041四川省中医药科学院中医研究所(四川省第二中医医院),成都,610031四川省中医药科学院,成都,610041||中药新药创制川渝共建重点实验室,成都,610041四川省中医药科学院中医研究所(四川省第二中医医院),成都,610031四川省中医药科学院,成都,610041||中药新药创制川渝共建重点实验室,成都,610041||中药品质及新药创制四川省重点实验室,成都,610041

医药卫生

十味咳喘方慢性阻塞性肺疾病气道高分泌黏蛋白核因子κB脂多糖信号通路

Shiwei Kechuan FormulaChronic obstructive pulmonary diseaseAirway mucus hypersecretionMucinsNF-κBLipopolysaccharideSignaling pathway

《世界中医药》 2026 (12)

2173-2181,9

"重大新药创制"国家科技重大专项(2018ZX09731-009)四川省区域创新合作项目(2024YFHZ0084)四川省中医药管理局科学技术研究专项(2023ZD006)四川省"天府万人计划"资助资金项目(川万人第407号)成都市技术创新研发项目(2024-YF05-02627-SN).

10.3969/j.issn.1673-7202.2026.12.003

评论